TcL Pharma becomes Effimune

Who are we ?
 Key points
 Events News
Company Scientific environnement
18/06/2012
Bio Boston
-------------------------------------------
02/06/2012
ATC Boston
-------------------------------------------
30/11/2011
European Antibody Congress, Geneva
-------------------------------------------
06/10/2011
International Connecting Day
-------------------------------------------
30/04/2011
American Transplant Congress, Philadelphia
-------------------------------------------
15/03/2011
Rhumatologie Dermatologie, Paris
-------------------------------------------
15/11/2010
Bio Europe 2010, Munich
-------------------------------------------
02/11/2010
First French Argentine Immunology Congress, Buenos Aires
-------------------------------------------
13/10/2010
Therapeutic Antibodies in Europe , London
-------------------------------------------
21/05/2012
CP Publication dans American Journal of Transplantation
-------------------------------------------
13/02/2012
PR TRIAD Project
-------------------------------------------
13/02/2012
CP Projet TRIAD
-------------------------------------------
11/07/2011
PR Effimune New name
-------------------------------------------
11/07/2011
CP Nouveau nom Effimune
-------------------------------------------
31/03/2011
PR 2 New appointments
-------------------------------------------
31/03/2011
CP 2 Nouvelles Nominations
-------------------------------------------
15/01/2011
CP Pays de Loire Développement
-------------------------------------------
18/11/2010
Prix "Le Monde" de la recherche universitaire
-------------------------------------------
Management Team Autoimmunity & Transplantation
R&D Team Expertise in immunomodulation
Board of Directors
Scientific Advisory Board